• Likely subscribers to this study report include:
  -- Those who are seeking in-depth information about the current status / current trends of foreign-based companies in Japan, and their parent companies, that have been implementing their global reorganization plans.
  -- Those who are seeking information of these companies, including the policy / structure / current status / background information on mergers, of their R&D / production / marketing units.
• A total of 45 such companies have been consolidated into 22 companies over the past decade. This trend has particularly marked from 2001 on.

This report is a revised edition of the "2001, Comprehensive Study / Analysis of Pharmaceutical Product Development Strategies, Vol. 4", a serial study that has been issued with several revised editions, and well accepted by our clients over the past 20 years. A unique study was conducted by Seed Planning, Inc., to provide updates on the R&D, manufacturing, and marketing strategies, structural organization, current status, and background information about mergers and acquisitions, for foreign-based pharmaceutical companies in which worldwide restructuring programs are being implemented.